MedPath

Comparison of pre-emptive metoclopramide and ondansetron on patients' pain, discomfort and nausea

Phase 3
Completed
Conditions
Pain, nausea and discomfort from nasal-gastric tube insertion.
Registration Number
IRCT20180717040509N3
Lead Sponsor
Mazandaran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
46
Inclusion Criteria

Patients with NG tube Indication

Exclusion Criteria

Age less than 18 years old
Lack of consciousness
Patients with unstable hemodynamic status (systolic blood pressure less than 90 mmHg)
Having a nose bleed
Anatomical problems in the nose
Traumatic patients
Sensitivity to Metoclopramide and Ondansetron
Use of Metoclopramide and Ondansetron interfering drugs
Pregnancy
Patients with nausea and vomiting problem
NG tube more than twice

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pain. Timepoint: Immediately, 30 and 60 minutes after NG tube insertion. Method of measurement: Visual Analgesic Score.;Nausea. Timepoint: Immediately, 30 and 60 minutes after NG tube insertion. Method of measurement: Visual Analgesic Score.;Discomfort. Timepoint: Immediately, 30 and 60 minutes after NG tube insertion. Method of measurement: Visual Analgesic Score.
Secondary Outcome Measures
NameTimeMethod
Bleeding after NG tube insertion. Timepoint: Immediately, 30 and 60 minutes after NG tube placement. Method of measurement: Visual Analgesic Score.;Vomiting after NG tube insertion. Timepoint: Immediately, 30 and 60 minutes after NG tube placement. Method of measurement: Visual Analgesic Score.
© Copyright 2025. All Rights Reserved by MedPath